Hotlinenewswire

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

Roche Launches 2 Media Reviews

LOS ANGELES—Roche Laboratories has launched two reviews for its Xenical fat-fighting drug and its influenza pill, Tamiflu: one for the two drugs’ general-market media buying account and another for direct response buying. The combined budget for the assignments is estimated at $50 million. Participating in the dual searches will be New York-based incumbents Impiric, a Young & Rubicam shop that handles Tamiflu direct response buying; Media Marketing Solutions, another Y&R entity that handles general market buying for Xenical and Tamiflu; and Initiative Media’s Media Direct Partners, which handles Xenical’s direct response buying account.

Publicis Exits SBC’s $185-250 Mil.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in